Expression of Mutant Huntingtin Blocks Exocytosis in PC12 Cells by Depletion of Complexin II
Overview
Authors
Affiliations
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by an expanded CAG repeat in the HD gene. We reported recently that complexin II, a protein involved in neurotransmitter release, is depleted from both the brains of mice carrying the HD mutation and from the striatum of post mortem HD brains. Here we show that this loss of complexin II is recapitulated in PC12 cells expressing the HD mutation and is accompanied by a dramatic decline in Ca2+-triggered exocytosis of neurotransmitter. Overexpression of complexin II (but not complexin I) rescued exocytosis, demonstrating that the decline in neurotransmitter release is a direct consequence of complexin II depletion. Complexin II depletion in the brain may account for some of the abnormalities in neurotransmission associated with HD.
Pradhan S, Gao R, Bush K, Zhang N, Wairkar Y, Sarkar P Front Cell Neurosci. 2022; 16:837576.
PMID: 35444517 PMC: 9013776. DOI: 10.3389/fncel.2022.837576.
Barron J, Hurley E, Parsons M Front Cell Neurosci. 2021; 15:689332.
PMID: 34211373 PMC: 8239291. DOI: 10.3389/fncel.2021.689332.
Park H Exp Neurobiol. 2018; 27(3):217-225.
PMID: 30022873 PMC: 6050413. DOI: 10.5607/en.2018.27.3.217.
Huntington's Disease and Diabetes: Chronological Sequence of its Association.
Montojo M, Aganzo M, Gonzalez N J Huntingtons Dis. 2017; 6(3):179-188.
PMID: 28968242 PMC: 5676851. DOI: 10.3233/JHD-170253.
Synaptic Vesicle-Recycling Machinery Components as Potential Therapeutic Targets.
Li Y, Kavalali E Pharmacol Rev. 2017; 69(2):141-160.
PMID: 28265000 PMC: 5394918. DOI: 10.1124/pr.116.013342.